新聞中心及演示文稿
上一篇文章   |   下一篇文章
創新平台, 監管信息公告 | 2013-04-24

Nutrition Science Partners announces initiation and treatment of the first Ulcerative Colitis patient in the global NATRUL Phase III trial for the novel botanical oral drug HMPL-004